Page last updated: 2024-09-03

ginsenoside rh2 and Invasiveness, Neoplasm

ginsenoside rh2 has been researched along with Invasiveness, Neoplasm in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Cai, N; Jin, X; Yang, Q; Zhang, Z1
Liang, L; Sun, P; Wang, J; Wang, Z; Xu, M; Yuan, Y; Zhang, Y1
Jin, YH; Li, H; Li, Y; Wang, YS; Zhang, S1
Cui, CH; Hou, JG; Jeon, BM; Kim, SC; Yun, YJ1
Fang, CY; Liang, ZH; Tang, GD; Tang, XP; Zhang, LY1
Hong, B; Niu, T; Wu, S; Zhang, Q1
Guan, N; Guo, W; Huo, X; Luo, J; Zhang, S; Zhang, Z1
Han, SJ; Hyun, JW; Kim, DH; Kim, HS; Kim, SY1

Other Studies

8 other study(ies) available for ginsenoside rh2 and Invasiveness, Neoplasm

ArticleYear
A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment.
    Nanomedicine (London, England), 2020, Volume: 15, Issue:1

    Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Biphenyl Compounds; Cell Proliferation; Cisplatin; Ginsenosides; Humans; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Pentacyclic Triterpenes; Sesquiterpenes; Triterpenes; Xenograft Model Antitumor Assays

2020
20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial-mesenchymal transition.
    Bioscience reports, 2020, 03-27, Volume: 40, Issue:3

    Topics: Antineoplastic Agents; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; China; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; Lymphatic Metastasis; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Signal Transduction; Vimentin

2020
(20S)G-Rh2 Inhibits NF-κB Regulated Epithelial-Mesenchymal Transition by Targeting Annexin A2.
    Biomolecules, 2020, 03-31, Volume: 10, Issue:4

    Topics: Annexin A2; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Ginsenosides; Humans; Neoplasm Invasiveness; NF-kappa B

2020
Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A.
    International journal of molecular sciences, 2019, Mar-12, Volume: 20, Issue:5

    Topics: Apoptosis; Breast; Breast Neoplasms; Bystander Effect; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cellular Senescence; Doxorubicin; Epithelial Cells; Female; Ginsenosides; Humans; Interleukin-6; Neoplasm Invasiveness

2019
Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.
    World journal of gastroenterology, 2013, Mar-14, Volume: 19, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Ginsenosides; Humans; Neoplasm Invasiveness; Pancreatic Neoplasms; Signal Transduction; Time Factors

2013
Inhibition of prostatic cancer growth by ginsenoside Rh2.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:4

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; Male; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Prostatic Neoplasms; Receptors, Transforming Growth Factor beta; Signal Transduction

2015
Ginsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:9

    Topics: Adult; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Ginsenosides; Glioblastoma; Humans; Male; Matrix Metalloproteinase 13; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Wound Healing

2015
Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
    Biochemical pharmacology, 2007, Dec-03, Volume: 74, Issue:11

    Topics: Astrocytoma; Binding Sites; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Enzymologic; Ginsenosides; Humans; Matrix Metalloproteinase 1; Matrix Metalloproteinase 14; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Molecular Structure; Neoplasm Invasiveness; NF-kappa B; Phosphorylation; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Tetradecanoylphorbol Acetate; Transcription Factor AP-1

2007